Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Nature 577, 308-310 (2020)
Updates & Corrections
Correction 04 February 2020: An earlier version of this Feature implied that the first practical demonstration of anti-CRISPR activity was in halting the gene-editing process in human cells. In fact, it was showing that anti-CRISPRs could limit off-target effects in human cells.
Bondy-Denomy, J., Pawluk, A., Maxwell, K. L. & Davidson, A. R. Nature 493, 429–432 (2013).
Pawluk, A. et al. Cell 167, 1829–1838.e9 (2016).
Rauch, B. J. et al. Cell 168, 150–158.e10 (2017).
Dong, D. et al. Nature 546, 436–439 (2017).
Shin, J. et al. Sci. Adv. 3, e1701620 (2017).
Hoffmann, M. D. et al. Nucleic Acids Res. 47, e75 (2019).
Hirosawa, M., Fujita, Y. & Saito, H. ACS Synth. Biol. 8, 1575–1582 (2019).
Lee, J. et al. RNA 25, 1421–1431 (2019).
Maji, B. et al. Cell 177, 1067–1079.e19 (2019).
Barkau, C. L., O’Reilly, D., Rohilla, K. J., Damha, M. J. & Gagnon, K. T. Nucleic Acid Ther. 29, 136–147 (2019).
Basgall, E. M. et al. Microbiology 164, 464–474 (2019).
Kyrou, K., Hammond, A., Galizi, R. et al. Nature Biotechnol. 36, 1062–1066 (2018).
Liu, X. S. et al. Cell 172, 979–992.e6 (2018).
Labrie, S. J. et al. Sci. Rep. 9, 13816 (2019).